Bottom line
SHSCX vs SCHLX: the short answer
SHSCX (Blackrock Health Sciences Opportunities Portfolio) and SCHLX (DWS Health and Wellness Fund) are both mutual funds.
But SHSCX is far broader, holding 155 positions to 65 for SCHLX, so beyond the top names it adds exposure SCHLX doesn't have.
SCHLX is cheaper at 1.06% vs 1.9% — a difference of $84 a year per $10,000 invested.
Updated Nov 19, 2026
SHSCX vs SCHLX side by side
| SHSCX | SCHLX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | BlackRock | DWS (Xtrackers) |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.9% | 1.06% |
| Annual cost per $10k | $190 | $106 |
| 10-yr cost on $10k (prospectus) | $2,016 | $1,294 |
| Max front load | 0% | 0% |
| 12b-1 fee | 1% | 0% |
| 1-yr return | +14.1% | — |
| 5-yr return (annualized) | +4.8% | — |
| 10-yr return (annualized) | +8.9% | — |
| Best quarter | — | — |
| Worst quarter | — | — |
| Net assets (fund) | $5.9B | $231.8M |
| Number of holdings | 155 | 65 |
| Portfolio turnover | 49% | 2% |
| Returns as of | Dec 31, 2025 | — |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
17 of SHSCX's top 25 holdings also appear in SCHLX's top 25.
| Holding | SHSCX | SCHLX |
|---|---|---|
| Eli Lilly & Company | 12.29% | 13.85% |
| Johnson & Johnson | 8.77% | 6.19% |
| Unitedhealth Group Inc | 6.10% | 5.73% |
| Merck & Company Inc | 4.94% | 4.85% |
| Gilead Sciences Inc | 4.19% | 2.78% |
| Abbvie Inc | 3.94% | 4.90% |
| Amgen Inc | 3.37% | 2.88% |
| Thermo Fisher Scientific Inc | 3.02% | 3.46% |
| Vertex Pharmaceuticals Inc | 2.74% | 2.45% |
| Pfizer Inc | 2.61% | 1.17% |
| Danaher Corp | 2.00% | 2.13% |
| Abbott Laboratories | 1.97% | 2.39% |
| Intuitive Surgical Inc | 1.95% | 2.69% |
| Boston Scientific Corp | 1.59% | 2.10% |
| Astrazeneca Plc | 1.21% | 3.80% |
Source: SEC Form N-PORT
SHSCX top 10
- Eli Lilly & Company — 12.29%
- Johnson & Johnson — 8.77%
- Unitedhealth Group Inc — 6.10%
- Merck & Company Inc — 4.94%
- Gilead Sciences Inc — 4.19%
- Abbvie Inc — 3.94%
- Amgen Inc — 3.37%
- Thermo Fisher Scientific Inc — 3.02%
- Vertex Pharmaceuticals Inc — 2.74%
- Pfizer Inc — 2.61%
SCHLX top 10
- Eli Lilly & Co — 13.85%
- Johnson & Johnson — 6.19%
- UnitedHealth Group Inc — 5.73%
- AbbVie Inc — 4.90%
- Merck & Co Inc — 4.85%
- AstraZeneca PLC — 3.80%
- Thermo Fisher Scientific Inc — 3.46%
- Novartis AG — 2.90%
- Amgen Inc — 2.88%
- Gilead Sciences Inc — 2.78%
FAQ
What is the difference between SHSCX and SCHLX?
Which is cheaper, SHSCX or SCHLX?
Should I own both SHSCX and SCHLX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.